All very good points. I think there is legitimacy and then there is non-legitimacy. I'm confident in my opinion but I appreciate that it differs from yours.
Mesoblast has a 8 of clubs. Cynata has a ace of diamonds.
Clubs are trumps. No inference to the Orange one.
Cynata should issue a statement on intended progress with GVHD. If they spell out the reasons and show feasibility it could be only good for Cynata. I suggest it might be time for reflection given what has happened. A statement would clear it all up. It is the only trial Cynata is paying for and the only FDA trial.
Cynata through Ross mainly has marketed themselves as a better Mesoblast over and over for years. Do you recall the coffee analogy. Yeah, nor do I - I do remember there was one that sort of made logical sense. Ha ha ha.
CYP Price at posting:
23.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)